January 2025

Ozempic® is now indicated to reduce the risk of kidney disease worsening, kidney failure, and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease The approval is based on the results of the pivotal FLOW phase 3b kidney outcomes trial and addresses a critical

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: